Pathophysiological investigation of the gastric surface mucous gel layer of patients with Helicobacter pylori infection by using immunoassays for trefoil factor family 2 and gastric gland mucous cell-type mucin in gastric juice

Digestive Diseases and Sciences

Volumn 56, Issue 12, 2011, Pages 3498-3506

  Kubota, Seiko ^a,b   Yamauchi, Kazuyoshi ^c   Sugano, Mitsutoshi ^a   Kawasaki, Kenji ^a   Sugiyama, Atsushi ^d   Matsuzawa, Kenji ^e   Akamatsu, Taiji ^f   Ohmoto, Yasukazu ^g   Ota, Hiroyoshi ^b  

^a SHINSHU UNIVERSITY HOSPITAL   (Japan)

^b SHINSHU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF TSUKUBA   (Japan)

^d Sugiyama Clinic   (Japan)

^e Department of Internal Medicine   (Japan)

^f Suzaka Hospital   (Japan)

^g OTSUKA PHARMACEUTICAL CO LTD   (Japan)

Author keywords

ELISA; Gastric juice; Helicobacter pylori; Mucin; TFF2

Indexed keywords

INTESTINAL TREFOIL FACTOR; STOMACH MUCIN; TREFOIL FACTOR FAMILY 2 PROTEIN; UNCLASSIFIED DRUG; PEPTIDE; TREFOIL FACTOR;

ADULT; ARTICLE; CONTROLLED STUDY; DUODENUM ULCER; ENZYME LINKED IMMUNOSORBENT ASSAY; ERADICATION THERAPY; FEMALE; GASTRIC SURFACE MUCOUS GEL LAYER; GASTRITIS; HELICOBACTER INFECTION; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; STOMACH GLAND; STOMACH JUICE; STOMACH MUCOSA; STOMACH ULCER; AGED; CHEMISTRY; COMPARATIVE STUDY; FOLLOW UP; HELICOBACTER PYLORI; IMMUNOBLOTTING; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; MIDDLE AGED; PATHOLOGY; REPRODUCIBILITY;

AGED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; GASTRIC JUICE; GASTRIC MUCINS; GASTRIC MUCOSA; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PEPTIDES; REPRODUCIBILITY OF RESULTS;

EID: 84856142021     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-011-1724-9     Document Type: Article

References (36)

1. Ota H, Katsuyama T, Ishii K, Nakayama J, Shiozawa T, Tsukahara Y. A dual staining method for identifying mucins of different gastric epithelial mucous cells. Histochem J. 1991;23:22-28.
2. Ota H, Katsuyama T. Alternating laminated array of two types of mucin in the human gastric surface mucous layer. Histochem J. 1992;24:86-92.
3. Ho SB, Takamura K, Anway R, Shekels LL, Toribara NW, Ota H. The adherent gastric mucous layer is composed of alternating layers of MUC5AC and MUC6 mucin proteins. Dig Dis Sci. 2004;49:1598-1606. (Pubitemid 39335542)
4. Tomasetto C, Rio MC, Gautier C, et al. hSP, the domain-duplicated homolog of pS2 protein, is co-expressed with pS2 in stomach but not in breast carcinoma. EMBO J. 1990;9:407-414.
5. Ruchaud-Sparagano MH, Westley BR, May FE. The trefoil protein TFF1 is bound to MUC5AC in human gastric mucosa. Cell Mol Life Sci. 2004;61:1946-1954. (Pubitemid 39094801)
6. Hanby AM, Poulsom R, Singh S, Elia G, Jeffery RE, Wright NA. Spasmolytic polypeptide is a major antral peptide: distribution of the trefoil peptides human spasmolytic polypeptide and pS2 in the stomach. Gastroenterology. 1993;105:1110-1116. (Pubitemid 23281500)
7. Thim L. Trefoil peptides: from structure to function. Cell Mol Life Sci. 1997;53:888-903. (Pubitemid 28021502)
8. Sands BE, Podolsky DK. The trefoil peptide family. Annu Rev Physiol. 1996;58:253-273. (Pubitemid 26106721)
9. Wong WM, Poulsom R, Wright NA. Trefoil peptides. Gut. 1999;44:890-895. (Pubitemid 29244230)
10. Hoffmann W. Trefoil factor family (TFF) peptides: regulators of mucosal regeneration and repair, and more. Peptides. 2004;25: 727-730. (Pubitemid 38721336)
11. Hoffmann W. Trefoil factors TFF (trefoil factor family) peptidetriggered signals promoting mucosal restitution. Cell Mol Life Sci. 2005;62:2932-2938. (Pubitemid 43004746)
12. Ota H, Hayama M, Momose M, et al. Co-localization of TFF2 with gland mucous cell mucin in gastric mucous cells and in extracellular mucous gel adherent to normal and damaged gastric mucosa. Histochem Cell Biol. 2006;126:617-625. (Pubitemid 44484906)
13. Ichikawa T, Ota H, Sugiyama A, et al. Effects of a novel histamine H2-receptor antagonist, lafutidine, on the mucus barrier of human gastric mucosa. J Gastroenterol Hepatol. 2007;22:1800-1805. (Pubitemid 47525074)
14. Suzuki K, Hayama M, Nakamura M, et al. Trefoil factor 2 in gland mucous cell mucin in the mucous gel covering normal or damaged gastric mucosa using the Mongolian gerbil model. Scand J Gastroenterol. 2006;41:1390-1397. (Pubitemid 44764400)
15. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet. 1984;1:1311-1315.
16. Peek RM Jr, Blaser MJ. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer. 2002;2:28-37. (Pubitemid 37328805)
17. Hidaka E, Ota H, Hidaka H, et al. Helicobacter pylori and two ultrastructurally distinct layers of gastric mucous cell mucins in the surface mucous gel layer. Gut. 2001;49:474-480. (Pubitemid 32896975)
18. Shimizu T, Akamatsu T, Sugiyama A, Ota H, Katsuyama T. Helicobacter pylori and the surface mucous gel layer of the human stomach. Helicobacter. 1996;1:207-218. (Pubitemid 126671163)
19. Kawakubo M, Ito Y, Okimura Y, et al. Natural antibiotic function of a human gastric mucin against Helicobacter pylori infection. Science. 2004;305:1003-1006. (Pubitemid 39071775)
20. Kubota S, Yamauchi K, Kumagai T, et al. Quantitative determination of gland mucous cells-type mucin using a monoclonal antibody, HIK1083: its pathophysiological changes in human gastric juice. Clin Chim Acta. 2007;377:261-267. (Pubitemid 44908261)
21. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680-685.
22. Asaka M, Kato M, Takahashi S, et al. Guidelines for the management of Helicobacter pylori infection in Japan: 2009 revised edition. Helicobacter. 2010;15:1-20.
23. Vestergaard EM, Brynskov J, Ejskjaer K, et al. Immunoassays of human trefoil factors 1 and 2: measured on serum from patients with inflammatory bowel disease. Scand J Clin Lab Invest. 2004;64:146-156. (Pubitemid 38491386)
24. Semple JI, Newton JL, Westley BR, May FE. Dramatic diurnal variation in the concentration of the human trefoil peptide TFF2 in gastric juice. Gut. 2001;48:648-655. (Pubitemid 32378585)
25. Matsuda K, Yamauchi K, Matsumoto T, Sano K, Yamaoka Y, Ota H. Quantitative analysis of the effect of Helicobacter pylori on the expressions of SOX2, CDX2, MUC2, MUC5AC, MUC6, TFF1, TFF2, and TFF3 mRNAs in human gastric carcinoma cells. Scand J Gastroenterol. 2008;43:25-33.
26. Van De Bovenkamp JH, Korteland-Van Male AM, Buller HA, Einerhand AW, Dekker J. Infection with Helicobacter pylori affects all major secretory cell populations in the human antrum. Dig Dis Sci. 2005;50:1078-1086. (Pubitemid 40864011)
27. Matsuzawa M, Ota H, Hayama M, et al. Helicobacter pylori infection up-regulates gland mucous cell-type mucins in gastric pyloric mucosa. Helicobacter. 2003;8:594-600. (Pubitemid 37553433)
28. Thim L, Madsen F, Poulsen SS. Effect of trefoil factors on the viscoelastic properties of mucus gels. Eur J Clin Invest. 2002; 32:519-527. (Pubitemid 36223422)
29. Tanaka S, Podolsky DK, Engel E, Guth PH, Kaunitz JD. Human spasmolytic polypeptide decreases proton permeation through gastric mucus in vivo and in vitro. Am J Physiol. 1997;272: G1473-G1480.
30. Playford RJ, Marchbank T, Chinery R, et al. Human spasmolytic polypeptide is a cytoprotective agent that stimulates cell migration. Gastroenterology. 1995;108:108-116.
31. Babyatsky MW, deBeaumont M, Thim L, Podolsky DK. Oral trefoil peptides protect against ethanol-and indomethacin-induced gastric injury in rats. Gastroenterology. 1996;110:489-497. (Pubitemid 26043882)
32. Hernandez C, Santamatilde E, McCreath KJ, et al. Induction of trefoil factor (TFF)1, TFF2 and TFF3 by hypoxia is mediated by hypoxia inducible factor-1: implications for gastric mucosal healing. Br J Pharmacol. 2009;156:262-272.
33. Bhattacharyya A, Chattopadhyay R, Hall EH, Mebrahtu ST, Ernst PB, Crowe SE. Mechanism of hypoxia-inducible factor 1 alphamediated Mcl1 regulation in Helicobacter pylori-infected human gastric epithelium. Am J Physiol Gastrointest Liver Physiol. 2010;299:G1177-G1186.
34. Rosler S, Haase T, Claassen H, et al. Trefoil factor 3 is induced during degenerative and inflammatory joint disease, activates matrix metalloproteinases, and enhances apoptosis of articular cartilage chondrocytes. Arthritis Rheum. 2010;62:815-825.
35. Enss ML, Cornberg M, Wagner S, et al. Proinflammatory cytokines trigger MUC gene expression and mucin release in the intestinal cancer cell line LS180. Inflamm Res. 2000;49:162-169. (Pubitemid 30262713)
36. Yamaoka Y, Kita M, Kodama T, Sawai N, Imanishi J. Helicobacter pylori cagA gene and expression of cytokine messenger RNA in gastric mucosa. Gastroenterology. 1996;110:1744-1752. (Pubitemid 26169211)